Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis

Abstract

No evidence was found that supports the use of omega 3 fatty acids for maintenance of remission in UC. Further studies using enteric coated capsules may be justified.

Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bowel Disease via Circulating Metabolites: A Mediation Mendelian Randomization Study

“…Despite the protective role on CD, our study provided little evidence to support the effect of omega-3 PUFAs on UC risk. Previous epidemiological studies also indicated that an increasing dietary intake of EPA or DHA had no association with a decreased risk or maintenance of remission in UC [37,48]. It is possible that inadequate supplementation or absorption resulted in lower concentrations of fatty acids in UC patients, thereby limiting their ability to trigger protective effects.…”

Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bowel Disease via Circulating Metabolites: A Mediation Mendelian Randomization Study

“…Despite the protective role on CD, our study provided little evidence to support the effect of omega-3 PUFAs on UC risk. Previous epidemiological studies also indicated that an increasing dietary intake of EPA or DHA had no association with a decreased risk or maintenance of remission in UC [37,48]. It is possible that inadequate supplementation or absorption resulted in lower concentrations of fatty acids in UC patients, thereby limiting their ability to trigger protective effects.…”

Nutrition in Pediatric Inflammatory Bowel Disease

“…There are, however, no human studies to investigate the influence of consumption of different types of food on IBD patients except for studies investigating supplementation with omega 3 for induction and maintenance of remission in IBD patients. The data in this field do not support routine use of omega 3 and therefore, the recommendations for IBD patients are the same as for the healthy population (67,68).…”

Efficient Attenuation of Dextran Sulfate Sodium-Induced Colitis by Oral Administration of 5,6-Dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic Acid in Mice

“…ω-3 PUFAs and fish oil have been focused as alternative options for IBD treatment. However, there were some reports showing its ineffectiveness against IBD and adverse effects [20,21]. And even in case where its beneficial effects were shown, a relatively large intakes of such fatty acids were required.…”

Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bowel Disease via Circulating Metabolites: A Mediation Mendelian Randomization Study

“…Despite the protective role on CD, our study provided little evidence to support the effect of omega-3 PUFAs on UC risk. Previous epidemiological studies also indicated that an increasing dietary intake of EPA or DHA had no association with a decreased risk or maintenance of remission in UC [37,48]. It is possible that inadequate supplementation or absorption resulted in lower concentrations of fatty acids in UC patients, thereby limiting their ability to trigger protective effects.…”

Nutrition in Pediatric Inflammatory Bowel Disease

“…There are, however, no human studies to investigate the influence of consumption of different types of food on IBD patients except for studies investigating supplementation with omega 3 for induction and maintenance of remission in IBD patients. The data in this field do not support routine use of omega 3 and therefore, the recommendations for IBD patients are the same as for the healthy population (67,68).…”

Efficient Attenuation of Dextran Sulfate Sodium-Induced Colitis by Oral Administration of 5,6-Dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic Acid in Mice

“…ω-3 PUFAs and fish oil have been focused as alternative options for IBD treatment. However, there were some reports showing its ineffectiveness against IBD and adverse effects [20,21]. And even in case where its beneficial effects were shown, a relatively large intakes of such fatty acids were required.…”

Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bowel Disease via Circulating Metabolites: A Mediation Mendelian Randomization Study

“…Despite the protective role on CD, our study provided little evidence to support the effect of omega-3 PUFAs on UC risk. Previous epidemiological studies also indicated that an increasing dietary intake of EPA or DHA had no association with a decreased risk or maintenance of remission in UC [37,48]. It is possible that inadequate supplementation or absorption resulted in lower concentrations of fatty acids in UC patients, thereby limiting their ability to trigger protective effects.…”

Nutrition in Pediatric Inflammatory Bowel Disease

“…There are, however, no human studies to investigate the influence of consumption of different types of food on IBD patients except for studies investigating supplementation with omega 3 for induction and maintenance of remission in IBD patients. The data in this field do not support routine use of omega 3 and therefore, the recommendations for IBD patients are the same as for the healthy population (67,68).…”

Efficient Attenuation of Dextran Sulfate Sodium-Induced Colitis by Oral Administration of 5,6-Dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic Acid in Mice

“…ω-3 PUFAs and fish oil have been focused as alternative options for IBD treatment. However, there were some reports showing its ineffectiveness against IBD and adverse effects [20,21]. And even in case where its beneficial effects were shown, a relatively large intakes of such fatty acids were required.…”